Whole Cell Target Engagement Identifies Novel Inhibitors of <i>Mycobacterium tuberculosis</i> Decaprenylphosphoryl-β-<scp>d</scp>-ribose Oxidase
Sarah M. Batt(University of Birmingham), Argyrides Argyrou(GlaxoSmithKline (United Kingdom)), Esther Pérez‐Herrán(GlaxoSmithKline (Spain)), Neeraj Dhar(École Polytechnique Fédérale de Lausanne), Gurdyal S. Besra(University of Birmingham), Mike Rees(GlaxoSmithKline (United Kingdom)), Lluís Ballell(GlaxoSmithKline (Spain)), Robert J. Young(Age UK), Mónica Cacho Izquierdo(GlaxoSmithKline (Spain)), Christopher J. Stubbs(GlaxoSmithKline (United Kingdom)), Bernadette Mouzon(GlaxoSmithKline (United Kingdom)), Jonathan P. Hutchinson(Evotec (United Kingdom)), Julia Castro Pichel(GlaxoSmithKline (France)), David Barros-Aguirre(GlaxoSmithKline (Spain)), Laura Vela-Glez Del Peral(GlaxoSmithKline (United Kingdom)), John D. McKinney(Albert Einstein College of Medicine)
Cited by 67
Related Papers
Role of the Major Antigen of <i>Mycobacterium tuberculosis</i> in Cell Wall Biogenesis
|Science|1997|734
Nuclear-encoded proteins target to the plastid in <i>Toxoplasma gondii</i> and <i>Plasmodium falciparum</i>
|Proceedings of the National Academy of Sciences|1998|703
Expanding the medicinal chemistry synthetic toolbox
|Nature Reviews Drug Discovery|2018|693
Pathway to Synthesis and Processing of Mycolic Acids in <i>Mycobacterium tuberculosis</i>
|Clinical Microbiology Reviews|2005|653